Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-25-000413
Filing Date
2025-05-08
Accepted
2025-05-08 12:41:13
Documents
38
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q notr10q033125.htm   iXBRL 10-Q 307213
2 EXHIBIT 31.1 notrex31-1.htm EX-31.1 12564
3 EXHIBIT 31.2 notrex31-2.htm EX-31.2 12683
4 EXHIBIT 32.1 notrex32-1.htm EX-32.1 4990
5 EXHIBIT 32.2 notrex32-2.htm EX-32.2 4562
  Complete submission text file 0001185185-25-000413.txt   1933130

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE notr-20250331.xsd EX-101.SCH 12678
7 XBRL CALCULATION FILE notr-20250331_cal.xml EX-101.CAL 18027
8 XBRL DEFINITION FILE notr-20250331_def.xml EX-101.DEF 70928
9 XBRL LABEL FILE notr-20250331_lab.xml EX-101.LAB 139988
10 XBRL PRESENTATION FILE notr-20250331_pre.xml EX-101.PRE 81351
40 EXTRACTED XBRL INSTANCE DOCUMENT notr10q033125_htm.xml XML 102018
Mailing Address 2722 S WEST TEMPLE SALT LAKE CITY UT 84115
Business Address 2722 S WEST TEMPLE SALT LAKE CITY UT 84115 801-949-0791
BioScience Health Innovations, Inc. (Filer) CIK: 0001784440 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-234487 | Film No.: 25924974
SIC: 7374 Services-Computer Processing & Data Preparation
(CF Office: 06 Technology)